Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

Technology appraisal guidance
Reference number: TA265
Published: 24 October 2012

Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - response to scrutiny letter

Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - response to scrutiny letter

Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - response to scrutiny letter
24 October 2012
(46.76 Kb 13 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 18 October 2012